Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease

Status:
Completed

Trial end date:
2020-12-22

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the effectiveness of OTO-104 for the treatment of Meniere's disease.

Phase 3

Otonomy, Inc.